Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238049023> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4238049023 endingPage "379" @default.
- W4238049023 startingPage "376" @default.
- W4238049023 abstract "Among persons who receive solid organ 0842 transplants, liver transplant recipients have the highest incidence of invasive fungal infection; however, no antifungal prophylaxis has been proven to be effective. To evaluate the efficacy and safety of prophylactic0842 fluconazole in liver transplant recipients. Randomized, double-blind, placebo-controlled trial. 0842 University-affiliated transplantation center.0842 212 liver transplant recipients who received fluconazole0842 (400 mg/d) or placebo until 10 weeks after transplantation. Fungal colonization, proven superficial 0842 or invasive fungal infection, drug-related side effects, and death. Fungal colonization increased in 0842 patients who received placebo (from 60% to 90%) but decreased in patients who received fluconazole (from 70% to 28%). Proven fungal infection occurred in 45 of 104 placebo recipients (43%) but in only 10 of 108 fluconazole recipients (9%) (P < 0.001). Fluconazole prevented both superficial infection (29 of 104 placebo recipients became infected [28%] compared with 4 of 108 fluconazole recipients [4%]; P < 0.001) and invasive infection (24 of 104 placebo recipients became infected [23%] compared with 6 of 108 fluconazole recipients [6%]; P < 0.001). Fluconazole prevented infection by most Candida species, except C. glabrata. However, infection and colonization by organisms intrinsically resistant to fluconazole did not seem to increase. Fluconazole was not associated with any hepatotoxicity. Patients receiving fluconazole had higher serum cyclosporine levels and more adverse neurologic events (headaches, tremors, or seizures in 13 fluconazole recipients compared with 3 placebo recipients; P = 0.01). Although the overall mortality rate was similar in both groups (12 of 108 [11%] in the fluconazole group compared with 15 of 104 [14%] in the placebo group; P > 0.2), fewer deaths related to invasive fungal infection were seen in the fluconazole group (2 of 108 patients [2%]) than in the placebo group (13 of 104 patients [13%]) (P = 0.003). Prophylactic 0842 fluconazole after liver transplantation decreases fungal colonization, prevents superficial and invasive fungal infections, and has no appreciable hepatotoxicity. Although fluconazole prophylaxis is associated with fewer deaths from fungal infection, it does not improve overall survival. Patients receiving prophylactic fluconazole require close monitoring of serum cyclosporine levels to avoid neurologic toxicity." @default.
- W4238049023 created "2022-05-12" @default.
- W4238049023 creator A5016041864 @default.
- W4238049023 date "2000-05-01" @default.
- W4238049023 modified "2023-10-17" @default.
- W4238049023 title "Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial" @default.
- W4238049023 doi "https://doi.org/10.1016/s1527-6465(05)80022-x" @default.
- W4238049023 hasPublicationYear "2000" @default.
- W4238049023 type Work @default.
- W4238049023 citedByCount "6" @default.
- W4238049023 countsByYear W42380490232015 @default.
- W4238049023 crossrefType "journal-article" @default.
- W4238049023 hasAuthorship W4238049023A5016041864 @default.
- W4238049023 hasConcept C126322002 @default.
- W4238049023 hasConcept C141071460 @default.
- W4238049023 hasConcept C142724271 @default.
- W4238049023 hasConcept C16005928 @default.
- W4238049023 hasConcept C197934379 @default.
- W4238049023 hasConcept C204787440 @default.
- W4238049023 hasConcept C27081682 @default.
- W4238049023 hasConcept C2779548794 @default.
- W4238049023 hasConcept C2779609443 @default.
- W4238049023 hasConcept C2780651595 @default.
- W4238049023 hasConcept C2780908437 @default.
- W4238049023 hasConcept C2911091166 @default.
- W4238049023 hasConcept C71924100 @default.
- W4238049023 hasConcept C90924648 @default.
- W4238049023 hasConceptScore W4238049023C126322002 @default.
- W4238049023 hasConceptScore W4238049023C141071460 @default.
- W4238049023 hasConceptScore W4238049023C142724271 @default.
- W4238049023 hasConceptScore W4238049023C16005928 @default.
- W4238049023 hasConceptScore W4238049023C197934379 @default.
- W4238049023 hasConceptScore W4238049023C204787440 @default.
- W4238049023 hasConceptScore W4238049023C27081682 @default.
- W4238049023 hasConceptScore W4238049023C2779548794 @default.
- W4238049023 hasConceptScore W4238049023C2779609443 @default.
- W4238049023 hasConceptScore W4238049023C2780651595 @default.
- W4238049023 hasConceptScore W4238049023C2780908437 @default.
- W4238049023 hasConceptScore W4238049023C2911091166 @default.
- W4238049023 hasConceptScore W4238049023C71924100 @default.
- W4238049023 hasConceptScore W4238049023C90924648 @default.
- W4238049023 hasIssue "3" @default.
- W4238049023 hasLocation W42380490231 @default.
- W4238049023 hasOpenAccess W4238049023 @default.
- W4238049023 hasPrimaryLocation W42380490231 @default.
- W4238049023 hasRelatedWork W134417478 @default.
- W4238049023 hasRelatedWork W1974953831 @default.
- W4238049023 hasRelatedWork W1984513537 @default.
- W4238049023 hasRelatedWork W1996236107 @default.
- W4238049023 hasRelatedWork W1997018272 @default.
- W4238049023 hasRelatedWork W2091491906 @default.
- W4238049023 hasRelatedWork W2117119663 @default.
- W4238049023 hasRelatedWork W2404931364 @default.
- W4238049023 hasRelatedWork W2415754622 @default.
- W4238049023 hasRelatedWork W2416084867 @default.
- W4238049023 hasVolume "6" @default.
- W4238049023 isParatext "false" @default.
- W4238049023 isRetracted "false" @default.
- W4238049023 workType "article" @default.